Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images
1
Zitationen
41
Autoren
2026
Jahr
Abstract
Für dieses Paper ist kein Abstract in der Datenbank hinterlegt.
Abstract beim Verlag einsehenÄhnliche Arbeiten
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene
1987 · 11.670 Zit.
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 · 11.440 Zit.
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 · 11.420 Zit.
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 · 9.372 Zit.
Cell Signaling by Receptor Tyrosine Kinases
2010 · 7.795 Zit.
Autoren
- Brittany A. McKelvey
- Pedro A Torres-Saavedra
- J Li
- Glenn Broeckx
- Frederik Deman
- Siraj M. Ali
- Hillary S. Andrews
- Salim Arslan
- Meir Azulay
- Santhosh Balasubramanian
- J.C. Barrett
- Peter D. Caie
- Ming Chen
- Daniel Cohen
- Tathagata Dasgupta
- Diana Fahrer
- George Green
- Mark Gustavson
- Sarah Hersey
- Ana Hidalgo-Sastre
- Shahanawaz Jiwani
- Elaine Joseph
- Wonkyung Jung
- Kimary Kulig
- Vladimir Kushnarev
- Jochen K. Lennerz
- Xiaoxian Li
- Meredith Lodge
- Joan Mancuso
- Mike Montalto
- Satabhisa Mukhopadhyay
- Foivos Ntelemis
- Matthew J. Oberley
- Pahini Pandya
- Puig Oscar
- Edward T. Richardson
- A. Sarachakov
- Mark Stewart
- Lisa M. McShane
- Roberto Salgado
- Jeff Allen
Institutionen
- Friends of Cancer Research(US)
- National Cancer Institute(US)
- University of Antwerp(BE)
- Ziekenhuisnetwerk Antwerpen Stuivenberg(BE)
- DZP Technologies (United Kingdom)(GB)
- American Academy of Implant Dentistry(US)
- Critical Path Institute(US)
- PathAI (United States)(US)
- University of North Carolina at Chapel Hill(US)
- Radiology Associates of Albuquerque(US)
- Caris Life Sciences (United States)(US)
- GlaxoSmithKline (United States)(US)
- Bodkin Design & Engineering (United States)(US)
- Clinical Research Consulting(US)
- AstraZeneca (United States)(US)
- Bristol-Myers Squibb (United States)(US)
- AstraZeneca (Germany)(DE)
- Frederick National Laboratory for Cancer Research(US)
- Accenture (United States)(US)
- Addgene(US)
- Emory University(US)
- Patient Advocate Foundation(US)
- Amgen (United States)(US)
- Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
- Peter MacCallum Cancer Centre(AU)